Efficacy and safety of mesenchymal stromal cells for the prophylaxis of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials

Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?

(2016) R. Zeiser et al.   BLOOD

Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis

(2016) Merete Kallekleiv et al.   CYTOTHERAPY

Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord–Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation

(2016) Lei Gao et al.   JOURNAL OF CLINICAL ONCOLOGY

Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation

(2016) Li Wang et al.   STEM CELLS AND DEVELOPMENT

Mesenchymal stem cells provide prophylaxis against acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: A meta-analysis of animal models

(2016) Li Wang et al.   Oncotarget

Cryopreservation does not alter main characteristics of Good Manufacturing Process–grade human multipotent mesenchymal stromal cells including immunomodulating potential and lack of malignant transformation

(2015) Jana Luetzkendorf et al.   CYTOTHERAPY

Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

(2015) Xiaomei Chen et al.   PLoS One

Analysis of results of acute graft-versus-host disease prophylaxis with donor multipotent mesenchymal stromal cells in patients with hemoblastoses after allogeneic bone marrow transplantation

(2014) I. N. Shipounova et al.   BIOCHEMISTRY-MOSCOW

The biology of graft-versus-host disease: experimental systems instructing clinical practice

(2014) K. A. Markey et al.   BLOOD

Current issues in chronic graft-versus-host disease

(2014) G. Socie et al.   BLOOD

Oral Sessions

(2014)   BONE MARROW TRANSPLANTATION

MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease

(2014) L Kordelas et al.   LEUKEMIA

CCR7 Guides Migration of Mesenchymal Stem Cell to Secondary Lymphoid Organs: A Novel Approach to Separate GvHD from GvL Effect

(2014) Hong Li et al.   STEM CELLS

Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?

(2014) Guido Moll et al.   STEM CELLS

Burden of Morbidity in 10+ Year Survivors of Hematopoietic Cell Transplantation: Report from the Bone Marrow Transplantation Survivor Study

(2013) Can-Lan Sun et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients

(2013) Martino Introna et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Co-transplantation of third-party umbilical cord blood-derived MSCs promotes engraftment in children undergoing unrelated umbilical cord blood transplantation

(2013) S H Lee et al.   BONE MARROW TRANSPLANTATION

Human Application of Ex Vivo Expanded Umbilical Cord-Derived Mesenchymal Stem Cells: Enhance Hematopoiesis after Cord Blood Transplantation

(2013) Kang-Hsi Wu et al.   CELL TRANSPLANTATION

The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?

(2013) Jacques Galipeau   CYTOTHERAPY

Mesenchymal Stromal Cell Characteristics Vary Depending on Their Origin

(2013) Heike Wegmeyer et al.   STEM CELLS AND DEVELOPMENT

Stability of human mesenchymal stem cells duringin vitroculture: considerations for cell therapy

(2012) R. Binato et al.   CELL PROLIFERATION

Cryopreservation of umbilical cord mesenchymal cells in xenofree conditions

(2012) Karen de Lima Prata et al.   CYTOTHERAPY

Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy

(2011) Lena von Bahr et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro

(2011) H. Karlsson et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

(2011) Moïra François et al.   CYTOTHERAPY

Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease—A Phase II Study

(2011) Larisa A. Kuzmina et al.   Stem Cells International

Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study

(2010) Vinod K. Prasad et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD

(2010) J Y Weng et al.   BONE MARROW TRANSPLANTATION

Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation

(2010) M E Bernardo et al.   BONE MARROW TRANSPLANTATION

Human Bone Marrow Stromal Cells and Skin Fibroblasts Inhibit Natural Killer Cell Proliferation and Cytotoxic Activity

(2010) Amandine Pradier et al.   CELL TRANSPLANTATION

Immunogenicity and Immunomodulatory Properties of Umbilical Cord Lining Mesenchymal Stem Cells

(2010) Tobias Deuse et al.   CELL TRANSPLANTATION

The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation

(2010) Erica Valencic et al.   CYTOTHERAPY

Pro-Inflammatory Cytokines, IFNγ and TNFα, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells Differentially

(2010) S. Jyothi Prasanna et al.   PLoS One

Coinfusion of Mesenchymal Stromal Cells Facilitates Platelet Recovery Without Increasing Leukemia Recurrence in Haploidentical Hematopoietic Stem Cell Transplantation: A Randomized, Controlled Clinical Study

(2010) Kaiyan Liu et al.   STEM CELLS AND DEVELOPMENT

Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease

(2009) Partow Kebriaei et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Sclerodermatous Chronic Graft-versus-Host Disease: Clinical Report

(2009) Hong Zhou et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells

(2009) H. Samuelsson et al.   CYTOTHERAPY

Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: Combined consequences for cell therapy in older recipients

(2009) Yufeng Zhuo et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses

(2008) H. Karlsson et al.   BLOOD

IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

(2008) David Polchert et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

(2008) Katarina Le Blanc et al.   LANCET

Mesenchymal stem cells for graft-versus-host disease: a double edged sword?

(2008) F Vianello et al.   LEUKEMIA

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study

(2008) H Ning et al.   LEUKEMIA